Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: A voxel-based FDG-positron emission tomography analysis

Journal of Neurology

Volumn 254, Issue 7, 2007, Pages 838-845

  Wang, P S ^a,b,c   Liu, R S ^d   Yang, B H ^d   Soong, B W ^a,b,d  

^a Taipe Veterans General Hospital   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MUNICIPAL GAN DAU HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Positron emission tomography; Spinocerebellar ataxia type 2; Spinocerebellar ataxia type 3; Spinocerebellar ataxia type 6

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GENOTYPE; GLUCOSE METABOLISM; HUMAN; LIMBIC SYSTEM; MALE; PONS; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION; SUBICULUM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN MAPPING; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPINOCEREBELLAR ATAXIAS;

EID: 34547670506     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0383-9     Document Type: Article

References (41)

1. Abele M, Burk K, Andres F, et al. (1997) Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain 120:2141-2148
2. Bang OY, Huh K, Lee PH, Kim HJ. (2003) Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds. Arch Neurol 60:1566-1574
3. Boesch SM, Schocke M, Burk K, et al. (2001) Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar types 2 and 6. J Magnet Res Imag 13:553-559
4. Brenneis C, Bosch SM, Schocke M, et al. (2003) Atrophy pattern in SCA2 determined by voxel-based morphometry. Neuroreport 14:1799-1802
5. Burk K, Globas C, Bosch S, et al. (1999) Cognitive deficits in spinocerebellar ataxia 2. Brain 122:769-777
6. Chen JT, Lin YY, Lee YC, et al. (2004) Prolonged central motor conduction time of lower limb muscles in spinocerebellar ataxia 6. J Clin Neurosci 11:381-383
7. Durr A, Smadja D, Cancel G, Lezin A, Stevanin G, Mikol J, Bellance R, Buisson GG, Chneiweiss H, Dellanave J, et al. (1995) Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118:1573-81
8. Estrada R, Galarraga J, Orozco G, Nodarse A, Auburger G. (1999) Spinocerebellar ataxia 2 (SCA2): morphometric analyses in 11 autopsies. Acta Neuropathol 97:306-10
9. Etchebehere EC, Cendes F, Lopes-Cendes I, et al. (2001) Brain single-photon emission computed tomography and magnetic resonance imaging in Machado- Joseph disease. Arch Neurol 58:1257-1263
10. Gilman S, Markel DS, Koeppe RA, et al. (1988) Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography. Ann Neurol 23:223- 230
11. Gilman S, Koeppe RA, Junck L, et al. (1994) Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 36:166-175
12. Giuffrida S, Saponara R, Restivo DA, et al. (1999) Supratentorial atrophy in spinocerebellar ataxia type 2: MRI study of 20 patients. J Neurol 246:383- 388
13. Globas C, Bosch S, Zuhlke CH, Daum I, Dichgans J, Burk K. (2003) The cerebellum and cognition. Intellectual function in spinocerebellar ataxia type 6. J Neurol 250:1482-1487
14. Gomez CM, Thompson RM, Gammack JT, Perlman SL, Dobyns WB, Truwit CL, Zee DS, Clark HB, Anderson JH. (1997) Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 42:933-50
15. Hayashi T, Nakajima T, Fukuhara N. (2001) Analysis of regional cerebral blood flow and distribution volume in Machado-Joseph disease by iodine)123I IMP single photon emission computed tomography. Rinsho Shinkeigaku - Clin Neurol 41:574-581
16. Kim YK, Lee DS, Lee SK, et al. (2003) Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med 44:1006-1012
17. Kuhl DE, Phelps ME, Markham CH, et al. (1982) Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol 12:425-434
18. Lee YC, Chen JT, Liao KK, Wu ZA, Soong BW. (2003) Prolonged cortical relay time and central motor conduction in patients with spinocerebellar ataxia type 6. Clin Neurophysiol 114:458-462
19. Leenders KL, Palmer AJ, Quinn N, et al. (1986) Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatr 49:853-860
20. Murata Y, Yamaguchi S, Kawakami H, et al. (1998) Characteristic magnetic resonance imaging findings in Machado- Joseph disease. Arch Neurol 55:33-37
21. Nestor PJ, Graham NL, Fryer TD, Williams GB, Patterson K, Hodges JR. (2003) Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain 126:2406-2418
22. Otsuka M, Ichiya Y, Kuwabara Y, et al. (1989) Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy. Ann Nucl Med 3:111-118
23. Poline JB, Worsley KJ, Holmes AP, et al. (1995) Estimating smoothness in statistical parametric maps: variability of p values. J Comput Assist Tomogr 19:788-796
24. Salmon E, Collette F, Degueldre C, Lemaire C, Franck G (2000) Voxelbased analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum Brain Mapp 10:39-48
25. Schols L, Peters S, Szymanski S, et al. (2000) Extrapyramidal motor signs in degenerative ataxias. Arch Neurol 57:1495-1500
26. Schwenkreis P, Tegenthoff M, Witscher K, et al. (2002) Motor cortex activation by transcranial magnetic stimulation in ataxia patients depends on the genetic defect. Brain 125:301-309
27. Shinotoh H, Thiessen B, Snow BJ, et al. (1997) Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease. Neurology 49:1133-1136
28. Soong B, Cheng C, Liu R, Shan D (1997) Machado-Joseph disease: clinical, molecular, and metabolic characterization in Chinese kindreds. Ann Neurol 41:446-452
29. Soong BW, Liu RS (1998) Positron emission tomography in asymptomatic gene carriers and patients with Machado- Joseph disease. J Neuro Neurosurg Psychiatr 64:499-504
30. Soong BW, Lu YC, Choo KB, Lee HY (2001) Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol 58:1105-1109
31. Soong B, Liu R, Wu L, et al. (2001) Metabolic characterization of spinocerebellar ataxia type 6. Arch Neurol 58:300-304
32. Storey E, Forrest SM, Shaw JH, et al. (1999) Spinocerebellar ataxia type 2: clinical features of a pedigree displaying prominent frontal-executive dysfunction. Arch Neurol 56:43-50
33. Takahashi H, Ikeuchi T, Honma Y, Hayashi S, Tsuji S (1998) Autosomal dominant cerebellar ataxia (SCA6): clinical, genetic and neuropathological study in a family. Acta Neuropathol 95:333-7
34. Takiyama Y, Oyanagi S, Kawashima S, Sakamoto H, Saito K, Yoshida M, Tsuji S, Mizuno Y, Nishizawa M (1994) A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology 44:1302-8
35. Talairach J, Tournoux P (1988) Coplanar stereotaxic atlas of the human brain 3-dimensional proportional system: an approach to cerebral imaging. New York: Thiemen Medical
36. Tang B, Liu C, Shen L, et al. (1997) Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 57:540-544
37. Taniwaki T, Sakai T, Kobayashi T, et al. (1997) Positron emission tomography (PET) in Machado-Joseph disease. J Neurol Sci 145:63-67
38. Trouillas P, Takayanagi T, Hallett M, et al. (1997) International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145:205-211
39. Varrone A, Salvatore E, De Michele G, et al. (2004) Reduced striatal [123 I]FPCIT binding in SCA2 patients without parkinsonism. Ann Neurol 55:426-430
40. Wullner U, Reimold M, Abele M, Burk K, Minnerop M, Dohmen BM, Machulla HJ, Bares R, Klockgether T (2005) Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Arch Neurol 62:1280-5
41. Zawacki TM, Grace J, Friedman JH, Sudarsky L (2002) Executive and emotional dysfunction in Machado-Joseph disease. Mov Disord 17:1004-1010